Squire Patton Boggs Advised Delmont Imaging On Sale To Rocamed

Squire Patton Boggs Advised Delmont Imaging on Sale to Rocamed

Squire Patton Boggs has advised the shareholders of Delmont Imaging on the sale of the company to Rocamed. This acquisition brings together two highly complementary French MedTech players with strong international presence.

Delmont Imaging, founded in 2016, is focused on improving care and healthcare measures for women by providing gynecological surgeons with innovative solutions. Its products, dedicated to diagnostic and surgical uterine procedures, are now registered in more than 50 countries across the world. Founded in 2011, Rocamed is a global medical device company specializing in endo-urology, developing, manufacturing and distributing a complete product range for urology, with a strong focus on stone management and prostate treatment.

The Squire Patton Boggs team was led by Paris Corporate Charles Fabry (Partner), and Anthony Guillaume (Partner), assisted by Victor Dransard (Associate), and Elise Crouzil (Associate).

Click to know more about Squire Patton Boggs

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.